These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1978891

  • 21. Prevalence and significance of anti-HCV antibodies.
    De Groote J.
    Acta Gastroenterol Belg; 1991; 54(3-4):248-56. PubMed ID: 1665270
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
    Marson P, Vicarioto M, Cavasin F, Volante D, De Silvestro G.
    Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hepatitis C virus antibodies in patients with liver disease. The western Cape experience.
    Robson SC, du Toit JM, Brice EA, Bird AR, Brink NS.
    S Afr Med J; 1991 Sep 21; 80(6):282-4. PubMed ID: 1656534
    [Abstract] [Full Text] [Related]

  • 26. [Anti-hepatitis C viral antibodies in different pathological entities in Chile].
    Velasco M, Hurtado C, Brahm J.
    Rev Med Chil; 1990 Aug 21; 118(8):895-6. PubMed ID: 1967082
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ethics of screening for hepatitis C virus.
    Flegg PJ.
    Lancet; 1989 Nov 18; 2(8673):1221. PubMed ID: 2572933
    [No Abstract] [Full Text] [Related]

  • 30. Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.
    Filice G, Patruno S, Campisi D, Chiesa A, Orsolini P, Debiaggi M, Bruno R, Tinelli M.
    New Microbiol; 1993 Jan 18; 16(1):35-42. PubMed ID: 7682283
    [Abstract] [Full Text] [Related]

  • 31. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M, Moshage H, Fevery J, Yap SH.
    Ned Tijdschr Geneeskd; 1992 Dec 26; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract] [Full Text] [Related]

  • 32. Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis.
    De Mercato R, Ciampi R, Romano A, Guarnaccia D, Siciliano V, Cantiello JP, Rippa O, Celentano U, Selva V, Romano C.
    Boll Soc Ital Biol Sper; 1990 Sep 26; 66(9):841-7. PubMed ID: 2127365
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus.
    Ikeda Y, Toda G, Hashimoto N, Kurokawa K.
    Lancet; 1990 Jun 02; 335(8701):1345-6. PubMed ID: 1971405
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P, Cursaro C, Miniero R, Stefanini GF, Sprovieri G, Gasbarrini G.
    Ital J Gastroenterol; 1991 Dec 02; 23(9):567-8. PubMed ID: 1662091
    [No Abstract] [Full Text] [Related]

  • 40. [Prevalence and significance of ant-HCV-antibodies in ambulatory patients with raised transaminases].
    Meier B, Joller H, Grob P, Ammann R, Altorfer J.
    Schweiz Med Wochenschr; 1991 May 25; 121(21):804-6. PubMed ID: 1647550
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.